Tectonic Therapeutic, Inc.
TECX
$27.96
$0.441.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 24.25% | 4.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.89% | -1.71% | |||
| Operating Income | -26.89% | 1.71% | |||
| Income Before Tax | -33.04% | 0.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.29% | -1.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.29% | -1.00% | |||
| EBIT | -26.89% | 1.71% | |||
| EBITDA | -27.45% | 1.69% | |||
| EPS Basic | -30.93% | -0.97% | |||
| Normalized Basic EPS | -32.68% | 0.36% | |||
| EPS Diluted | -30.93% | -0.97% | |||
| Normalized Diluted EPS | -32.68% | 0.36% | |||
| Average Basic Shares Outstanding | 0.27% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||